{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:20:22Z","timestamp":1794612022039,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pemphigoid diseases refer to a group of severe autoimmune skin blistering diseases characterized by subepidermal blistering and loss of dermal-epidermal adhesion induced by autoantibody and immune cell infiltrate at the dermal-epidermal junction and upper dermis. Here, we explore the role of the immune cell-secreted serine protease, granzyme B, in pemphigoid disease pathogenesis using three independent murine models. In all models, granzyme B knockout or topical pharmacological inhibition significantly reduces total blistering area compared to controls. In vivo and in vitro studies show that granzyme B contributes to blistering by degrading key anchoring proteins in the dermal-epidermal junction that are necessary for dermal-epidermal adhesion. Further, granzyme B mediates IL-8\/macrophage inflammatory protein-2 secretion, lesional neutrophil infiltration, and lesional neutrophil elastase activity. Clinically, granzyme B is elevated and abundant in human pemphigoid disease blister fluids and lesional skin. Collectively, granzyme B is a potential therapeutic target in pemphigoid diseases.<\/jats:p>","DOI":"10.1038\/s41467-020-20604-3","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T13:36:08Z","timestamp":1610458568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Granzyme B inhibition reduces disease severity in autoimmune blistering diseases"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-2272","authenticated-orcid":false,"given":"Sho","family":"Hiroyasu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Zeglinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8709-5115","authenticated-orcid":false,"given":"Megan A.","family":"Pawluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-4386","authenticated-orcid":false,"given":"Christopher T.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Kasprick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nishie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Burleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Lennox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Van Laeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsuruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-1737","authenticated-orcid":false,"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-2816","authenticated-orcid":false,"given":"David J.","family":"Granville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"20604_CR1","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt, E. & Zillikens, D. Pemphigoid diseases. Lancet 381, 320\u2013332 (2013).","journal-title":"Lancet"},{"key":"20604_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","volume":"8","author":"RJ Ludwig","year":"2017","unstructured":"Ludwig, R. J. et al. Mechanisms of autoantibody-induced pathology. Front. Immunol. 8, 603 (2017).","journal-title":"Front. Immunol."},{"key":"20604_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00220","volume":"5","author":"K Kridin","year":"2018","unstructured":"Kridin, K. & Ludwig, R. J. The growing incidence of bullous pemphigoid: overview and potential explanations. Front. Med. 5, 1\u20137 (2018).","journal-title":"Front. Med."},{"key":"20604_CR4","doi-asserted-by":"publisher","unstructured":"Kirtschig, G. et al. Interventions for bullous pemphigoid. Cochrane Database Syst. Rev. CD002292 https:\/\/doi.org\/10.1002\/14651858.CD002292.pub3 (2010).","DOI":"10.1002\/14651858.CD002292.pub3"},{"key":"20604_CR5","doi-asserted-by":"crossref","unstructured":"Hiroyasu, S., Turner, C. T., Richardson, K. C. & Granville, D. J. Proteases in pemphigoid diseases. Front. Immunol. 10, 1454 (2019).","DOI":"10.3389\/fimmu.2019.01454"},{"key":"20604_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/JCI3693","volume":"105","author":"Z Liu","year":"2000","unstructured":"Liu, Z. et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 105, 113\u2013123 (2000).","journal-title":"J. Clin. Invest."},{"key":"20604_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0092-8674(00)00087-8","volume":"102","author":"Z Liu","year":"2000","unstructured":"Liu, Z. et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 in vivo. Cell 102, 647\u2013655 (2000).","journal-title":"Cell"},{"key":"20604_CR8","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1158\/1078-0432.CCR-17-2469","volume":"24","author":"MA Shah","year":"2018","unstructured":"Shah, M. A. et al. Andecaliximab\/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: results from a phase I study. Clin. Cancer Res. 24, 3829\u20133837 (2018).","journal-title":"Clin. Cancer Res."},{"key":"20604_CR9","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jid.2018.03.1499","volume":"138","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. Neutrophil adhesion is a prerequisite for antibody-mediated proteolytic tissue damage in experimental models of epidermolysis bullosa acquisita. J. Invest. Dermatol. 138, 1990\u20131998 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"20604_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-28070-0","volume":"8","author":"V Russo","year":"2018","unstructured":"Russo, V. et al. Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"20604_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/jcp.2006.037010","volume":"60","author":"MR Hussein","year":"2007","unstructured":"Hussein, M. R., Ali, F. M. N. & Omar, A.-E. M. M. Immunohistological analysis of immune cells in blistering skin lesions. J. Clin. Pathol. 60, 62\u201371 (2007).","journal-title":"J. Clin. Pathol."},{"key":"20604_CR12","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","volume":"89","author":"WA Boivin","year":"2009","unstructured":"Boivin, W. A., Cooper, D. M., Hiebert, P. R. & Granville, D. J. Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab. Investig. 89, 1195\u20131220 (2009).","journal-title":"Lab. Investig."},{"key":"20604_CR13","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1016\/j.molimm.2007.03.024","volume":"44","author":"MCM Strik","year":"2007","unstructured":"Strik, M. C. M. et al. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol. Immunol. 44, 3462\u20133472 (2007).","journal-title":"Mol. Immunol."},{"key":"20604_CR14","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1038\/sj.cdd.4402183","volume":"14","author":"J Pardo","year":"2007","unstructured":"Pardo, J. et al. Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ. 14, 1768\u20131779 (2007).","journal-title":"Cell Death Differ."},{"key":"20604_CR15","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1182\/blood-2004-03-0859","volume":"104","author":"WJ Grossman","year":"2004","unstructured":"Grossman, W. J. et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104, 2840\u20132848 (2004).","journal-title":"Blood"},{"key":"20604_CR16","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1074\/jbc.M512694200","volume":"281","author":"H Hernandez-Pigeon","year":"2006","unstructured":"Hernandez-Pigeon, H. et al. Human keratinocytes acquire cellular cytotoxicity under UV-B irradiation: implication of granzyme B and perforin. J. Biol. Chem. 281, 13525\u201313532 (2006).","journal-title":"J. Biol. Chem."},{"key":"20604_CR17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/cdd.2009.169","volume":"17","author":"D Kaiserman","year":"2010","unstructured":"Kaiserman, D. & Bird, P. I. Control of granzymes by serpins. Cell Death Differ. 17, 586\u2013595 (2010).","journal-title":"Cell Death Differ."},{"key":"20604_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00403-013-1382-1","volume":"306","author":"T Akeda","year":"2014","unstructured":"Akeda, T. et al. CD8+ T cell granzyme B activates keratinocyte endogenous IL-18. Arch. Dermatol. Res. 306, 125\u2013130 (2014).","journal-title":"Arch. Dermatol. Res."},{"key":"20604_CR19","doi-asserted-by":"publisher","first-page":"23549","DOI":"10.1074\/jbc.M412001200","volume":"280","author":"MS Buzza","year":"2005","unstructured":"Buzza, M. S. et al. Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin. J. Biol. Chem. 280, 23549\u201323558 (2005).","journal-title":"J. Biol. Chem."},{"key":"20604_CR20","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1002\/cpph.55","volume":"84","author":"A Kasprick","year":"2019","unstructured":"Kasprick, A., Bieber, K. & Ludwig, R. J. Drug discovery for pemphigoid diseases. Curr. Protoc. Pharmacol. 84, e55 (2019).","journal-title":"Curr. Protoc. Pharmacol."},{"key":"20604_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1164\/ajrccm.161.5.9908090","volume":"161","author":"GM Gauvreau","year":"2000","unstructured":"Gauvreau, G. M. et al. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am. J. Respir. Crit. Care Med. 161, 1473\u20131478 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"20604_CR22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1189\/jlb.0609400","volume":"86","author":"T Ugajin","year":"2009","unstructured":"Ugajin, T. et al. Basophils preferentially express mouse mast cell protease 11 among the mast cell tryptase family in contrast to mast cells. J. Leukoc. Biol. 86, 1417\u20131425 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"20604_CR23","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1242\/jcs.02340","volume":"118","author":"S Wang","year":"2005","unstructured":"Wang, S., Dangerfield, J. P., Young, R. E. & Nourshargh, S. PECAM-1, 6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. J. Cell Sci. 118, 2067\u20132076 (2005).","journal-title":"J. Cell Sci."},{"key":"20604_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0095-0","volume":"50","author":"Y Shen","year":"2018","unstructured":"Shen, Y. et al. Topical small molecule granzyme B inhibitor improves remodeling in a murine model of impaired burn wound healing. Exp. Mol. Med. 50, 68 (2018).","journal-title":"Exp. Mol. Med."},{"key":"20604_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","volume":"13","author":"W Nishie","year":"2007","unstructured":"Nishie, W. et al. Humanization of autoantigen. Nat. Med. 13, 378\u2013383 (2007).","journal-title":"Nat. Med."},{"key":"20604_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2005.10.023","volume":"117","author":"DA Plager","year":"2006","unstructured":"Plager, D. A. et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J. Allergy Clin. Immunol. 117, 626\u2013634 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"20604_CR27","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.4049\/jimmunol.170.4.1854","volume":"170","author":"A Genovese","year":"2003","unstructured":"Genovese, A. et al. Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc\u03b5RI + cells through interaction with the \u03ba light chains of IgE. J. Immunol. 170, 1854\u20131861 (2003).","journal-title":"J. Immunol."},{"key":"20604_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1046\/j.0022-202x.2001.01521.x","volume":"117","author":"S Verraes","year":"2001","unstructured":"Verraes, S., Hornebeck, W., Polette, M., Borradori, L. & Bernard, P. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (Type XVII Collagen) in human bullous pemphigoid. J. Invest. Dermatol. 117, 1091\u20131096 (2001).","journal-title":"J. Invest. Dermatol."},{"key":"20604_CR29","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1172\/JCI23977","volume":"115","author":"Z Liu","year":"2005","unstructured":"Liu, Z. et al. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115, 879\u2013887 (2005).","journal-title":"J. Clin. Invest."},{"key":"20604_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1172\/JCI116674","volume":"92","author":"MD Kramer","year":"1993","unstructured":"Kramer, M. D. & Reinartz, J. The autoimmune blistering skin disease bullous pemphigoid: The presence of plasmin\/\u03b12-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin. J. Clin. Invest. 92, 978\u2013983 (1993).","journal-title":"J. Clin. Invest."},{"key":"20604_CR31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.yexcr.2007.01.006","volume":"313","author":"SC Pawar","year":"2007","unstructured":"Pawar, S. C., Demetriou, M. C., Nagle, R. B., Bowden, G. T. & Cress, A. E. Integrin alpha6 cleavage: a novel modification to modulate cell migration. Exp. Cell Res. 313, 1080\u20131089 (2007).","journal-title":"Exp. Cell Res."},{"key":"20604_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00217","volume":"5","author":"S Taylor","year":"2018","unstructured":"Taylor, S., Dirir, O., Zamanian, R. T., Rabinovitch, M. & Thompson, A. A. R. The role of neutrophils and neutrophil elastase in pulmonary arterial hypertension. Front. Med. 5, 1\u20131 (2018).","journal-title":"Front. Med."},{"key":"20604_CR33","first-page":"869","volume":"139","author":"JN Barker","year":"1991","unstructured":"Barker, J. N. et al. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am. J. Pathol. 139, 869\u2013876 (1991).","journal-title":"Am. J. Pathol."},{"key":"20604_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2133.1998.02169.x","volume":"138","author":"F Ameglio","year":"1998","unstructured":"Ameglio, F. et al. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br. J. Dermatol. 138, 611\u2013614 (1998).","journal-title":"Br. J. Dermatol."},{"key":"20604_CR35","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1172\/JCI17891","volume":"116","author":"KC Nelson","year":"2006","unstructured":"Nelson, K. C. et al. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J. Clin. Invest. 116, 2892\u20132900 (2006).","journal-title":"J. Clin. Invest."},{"key":"20604_CR36","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1172\/JCI119639","volume":"100","author":"Z Liu","year":"1997","unstructured":"Liu, Z. et al. A major role for neutrophils in experimental bullous pemphigoid. J. Clin. Invest. 100, 1256\u20131263 (1997).","journal-title":"J. Clin. Invest."},{"key":"20604_CR37","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI11494","volume":"108","author":"R Chen","year":"2001","unstructured":"Chen, R. et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108, 1151\u20131158 (2001).","journal-title":"J. Clin. Invest."},{"key":"20604_CR38","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1600-0625.2012.01529.x","volume":"21","author":"F Van den Bergh","year":"2012","unstructured":"Van den Bergh, F., Eliason, S. L., Burmeister, B. T. & Giudice, G. J. Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8. Exp. Dermatol. 21, 605\u2013611 (2012).","journal-title":"Exp. Dermatol."},{"key":"20604_CR39","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1002\/eji.201343941","volume":"43","author":"CN Zorn","year":"2013","unstructured":"Zorn, C. N. et al. Secretory lysosomes of mouse mast cells store and exocytose active caspase-3 in a strictly granzyme B dependent manner. Eur. J. Immunol. 43, 3209\u20133218 (2013).","journal-title":"Eur. J. Immunol."},{"key":"20604_CR40","doi-asserted-by":"crossref","unstructured":"Fortelny, N. et al. Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol. 12, e1001869 (2014).","DOI":"10.1371\/journal.pbio.1001869"},{"key":"20604_CR41","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1182\/blood-2006-03-010348","volume":"108","author":"CM Tschopp","year":"2006","unstructured":"Tschopp, C. M. et al. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 108, 2290\u20132299 (2006).","journal-title":"Blood"},{"key":"20604_CR42","doi-asserted-by":"crossref","unstructured":"Wada, M. et al. Epitope-dependent pathogenicity of antibodies targeting a major bullous pemphigoid autoantigen collagen XVII\/BP180. J. Invest. Dermatol. 136, 938\u2013946 (2016).","DOI":"10.1016\/j.jid.2015.11.030"},{"key":"20604_CR43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","volume":"182","author":"S Hiroyasu","year":"2013","unstructured":"Hiroyasu, S. et al. Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway. Am. J. Pathol. 182, 828\u2013840 (2013).","journal-title":"Am. J. Pathol."},{"key":"20604_CR44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","volume":"129","author":"H Iwata","year":"2009","unstructured":"Iwata, H. et al. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J. Invest. Dermatol. 129, 919\u2013926 (2009).","journal-title":"J. Invest. Dermatol."},{"key":"20604_CR45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/eji.201444769","volume":"45","author":"A Kasprick","year":"2015","unstructured":"Kasprick, A. et al. Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. Eur. J. Immunol. 45, 1462\u20131470 (2015).","journal-title":"Eur. J. Immunol."},{"key":"20604_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/j.1398-9995.2011.02570.x","volume":"66","author":"Y Ito","year":"2011","unstructured":"Ito, Y. et al. Basophil recruitment and activation in inflammatory skin diseases. Allergy 66, 1107\u20131113 (2011).","journal-title":"Allergy"},{"key":"20604_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1067\/mai.2000.107931","volume":"106","author":"CL Kepley","year":"2000","unstructured":"Kepley, C. L. et al. Negative regulation of Fc\u03f5RI signaling by Fc\u03b3RII costimulation in human blood basophils. J. Allergy Clin. Immunol. 106, 337\u2013348 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"20604_CR48","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/bjd.15924","volume":"177","author":"PC Freire","year":"2017","unstructured":"Freire, P. C., Mu\u00f1oz, C. H. & Stingl, G. IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants. Br. J. Dermatol. 177, 1644\u20131653 (2017).","journal-title":"Br. J. Dermatol."},{"key":"20604_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.immuni.2008.02.008","volume":"28","author":"Y Tsujimura","year":"2008","unstructured":"Tsujimura, Y. et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 28, 581\u2013589 (2008).","journal-title":"Immunity"},{"key":"20604_CR50","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1182\/blood-2007-01-068718","volume":"110","author":"K Obata","year":"2007","unstructured":"Obata, K. et al. Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110, 913\u2013920 (2007).","journal-title":"Blood"},{"key":"20604_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jdermsci.2012.06.005","volume":"67","author":"G Jin","year":"2012","unstructured":"Jin, G. et al. Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction. J. Dermatol. Sci. 67, 181\u2013189 (2012).","journal-title":"J. Dermatol. Sci."},{"key":"20604_CR52","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1161\/01.ATV.0000174797.71708.97","volume":"25","author":"M Kinoshita","year":"2005","unstructured":"Kinoshita, M., Okada, M., Hara, M., Furukawa, Y. & Matsumori, A. Mast cell tryptase in mast cell granules enhances MCP-1 and interleukin-8 production in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25, 1858\u20131863 (2005).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"20604_CR53","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1165\/rcmb.2007-0082OC","volume":"38","author":"CS Mullan","year":"2008","unstructured":"Mullan, C. S. et al. \u03b2-Tryptase regulates IL-8 expression in airway smooth muscle cells by a PAR-2\u2013Independent Mechanism. Am. J. Respir. Cell Mol. Biol. 38, 600\u2013608 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"20604_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly, P. et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N. Engl. J. Med. 346, 321\u2013327 (2002).","journal-title":"N. Engl. J. Med."},{"key":"20604_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0076-6879(00)22013-2","volume":"322","author":"L Shi","year":"2000","unstructured":"Shi, L., Yang, X., Froelich, C. J. & Greenberg, A. H. Purification and use of granzyme B. Methods Enzymol. 322, 125\u2013143 (2000).","journal-title":"Methods Enzymol."},{"key":"20604_CR56","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","volume":"34","author":"A Dudeck","year":"2011","unstructured":"Dudeck, A. et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34, 973\u2013984 (2011).","journal-title":"Immunity"},{"key":"20604_CR57","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11248-007-9153-4","volume":"17","author":"J Scholten","year":"2008","unstructured":"Scholten, J. et al. Mast cell-specific Cre\/loxP-mediated recombination in vivo. Transgenic Res. 17, 307\u2013315 (2008).","journal-title":"Transgenic Res."},{"key":"20604_CR58","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jss.2008.05.002","volume":"153","author":"MC Cheung","year":"2009","unstructured":"Cheung, M. C. et al. Body surface area prediction in normal, hypermuscular, and obese mice. J. Surg. Res. 153, 326\u2013331 (2009).","journal-title":"J. Surg. Res."},{"key":"20604_CR59","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/sj.jid.5700450","volume":"126","author":"H Kawasaki","year":"2006","unstructured":"Kawasaki, H. et al. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. J. Invest. Dermatol. 126, 2621\u20132630 (2006).","journal-title":"J. Invest. Dermatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20604-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T11:04:18Z","timestamp":1674817458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-20604-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["20604"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-20604-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739359692.793585615","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.J.G. is a Co-Founder, Chief Scientific Officer, and Consultant of viDA Therapeutics, Inc., which developed VTI-1002, a granzyme B inhibitor used in this manuscript. The remaining authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}